TLRs toll for Tregs. by Aksoy, E

Received: 7 June 2019 Revised: 3 August 2019 Accepted: 5 August 2019
DOI: 10.1002/JLB.2CE0619-184R
E D I TO R I A L COMMEN TARY
TLRs toll for Tregs
▶See corresponding article on Page 1201
Food allergy (FA) is an immune mediated pathologic condition in
response to normally innocuous food antigens with the prevalence
increasing in both Western and fast-developing countries. Food aller-
gensarederived fromcommon foodproteinsof plant andanimal origin.
The adverse immune responses in FA consist of IgE-mediated imme-
diate hypersensitivity reactions, non-IgE-mediated reactions, and
conditions involving mixed IgE-mediated and cell-mediated immune
reactions.1–3 The allergic responses are mediated by the partici-
pation of a range of innate and adaptive immune cells, such as
mast cells, basophils, and eosinophils, type 2 innate lymphoid cells
(ILC2s) as well as activated Th2 cells and B cells switched to the
production of IgE.
Although the processes by which the immune regulatory mecha-
nismsmaintain tolerance to allergens remain enigmatic, the pathogen-
esis of allergic diseases is generally accepted to involve an ineffective
immune tolerance to allergens. Regulatory T cells (Tregs) are a subset
of CD4+ T lymphocytes, characterized by the expression of tran-
scription factor FOXP3.4 They play a key role in maintaining immune
tolerance to food antigens and commensal microbiota in the gut. The
professional antigen presenting cells, such as dendritic cells (DCs),
process and present peptides from food antigens on their MHC class
II molecules, and subsequently orchestrate antigen-specific T cell
responses. The induction of protective T cell responses requires naïve
T cells to receive signals via the TCR, costimulatory molecules, and
cytokine receptors. These signals are generally provided by tolero-
genic DCs in the gut-associated lymphoid tissue (GALT),5 the largest
immune organ in the body. Currently, mechanisms regulating oral tol-
erance to food antigens are not well understood, but may involve gut
microorganisms as sources of natural antigens that continuously stim-
ulate theGALT and inducemucosal immune tolerance to food antigens
together with the molecular components derived from commensal
bacteria.5 DCs are stimulated when they encounter pathogen-
associated molecular patterns (PAMPs) from microorganisms that
are recognized by pathogen recognition receptors, of which TLRs
represent one of the most important and evolutionarily conserved
families. TLRs recognize conserved molecular structures expressed
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by microorganisms, including bacteria, viruses, fungi, and protozoa.
TLR engagement by their cognate ligands in DCs alerts the immune
system to pathogenic threat and leads to the activation of innate
immune response, resulting in the production of proinflammatory
cytokines, chemokines, and increased phagocytic capacity and antigen
presentation along other innate effector mechanisms. Pathogen
recognition via TLRs activates the innate immunity, which then
results in the orchestration of ensuing adaptive immune response.
Although a number of TLRs, including the LPS receptor TLR4, are
found on the plasma membrane, TLR3, TLR7, TLR8, and TLR9 reside
on the endomembranes, in intracellular locations, where they sense
the presence of intracellular pathogens such as virus and bacteria
or their microbial derived ligands. For example, TLR3 recognizes
double-stranded RNA structures whereas TLR7/8 sense single-
stranded RNA and TLR9 can detect nonmethylated CpG DNA from
virus or bacteria.
TLR recognition of PAMPs are generally accepted to occur through
innate immune cells such as DCs, which may prime Tregs; however,
accumulating evidence suggests that TLR signaling may directly con-
trol Tregs suppressive functions. For example, stimulation of human
Tregs with TLR5 ligand, flagellin increases their suppressive function.6
Bacterial polysaccharides as TLR2 ligands can also induce Tregs
through DCs7 and TLR2-deficient mice display reduced numbers of
CD4+ CD25+ Treg cells.8 In vitro, TLR2 ligand Pam3Cys, but not LPS
(TLR4) or CpG (TLR9), was shown to act directly on Tregs in aMyD88-
dependent fashion, augmenting Treg proliferation in vitro and in vivo.9
Interestingly budesonide treatment of asthmatic patients results in
increased TLR2 and TLR4 expression on their Tregs and ligation of
TLR4 by LPS was found to increase FOXP3 expression in Tregs from
both asthmatic patients and healthy donors.10 Overall accumulating
evidence suggests that steady state or de novo expression of a number
of TLRs expressed in diverse locations in Tregs have functional roles
that remain to be determined.
The study by Hong et al., published in this issue, adds a new twist
to the emerging role of TLRs as positive regulators of Treg functions
in the intestine. Far from being an inert intracellular innate immune
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F IGURE 1 The cartoon depicts transcriptional effects of polyI:C in
T cells alleviating pathological immune response in FA
receptor, TLR3 is expressed by the lamina propria T cells, and follow-
ing triggering by polyinosinic polycytidylic acid (polyI:C), an analogue
of double-stranded RNA mirroring viral infection, results in the acti-
vation of induced Tregs (iTregs) (Fig. 1). The study shows that polyI:C
exposed lamina propria CD4+ T cells in the colon express high levels
of FOXP3 and IFN𝛾 , with potent immunosuppressive functions, which
can be mirrored by polyI:C exposure of splenic naïve CD4+ T cells
in vitro since they exhibited higher suppressive capacity in inhibiting
effector T cell proliferation in comparison to Tregs expressing solely
FOXP3. The authors discovered a selective association between the
transcription factors, T-bet (T-box transcription factor, driving Th1)
and GATA binding protein 3 (GATA3, driving Th2) from the immuno-
precipitates of the cell lysates, obtained from the lamina propria CD4+
T cells of mice orally administered polyI:C or alternatively from splenic
CD4+ T cells, activated by polyI:C in vitro. The T-bet levels in iTregs
were found markedly augmented following both in vivo or in vitro
exposure to polyI:C. The authors used immunoprecipitation and later
chromatin immunoprecipitation assays elegantly to demonstrate that
T-bet competitively and selectively complexedwith GATA3, thus liber-
ating and rendering FOXP3 transcriptionally active. Upon release from
GATA3, FOXP3 was found to translocate and associate with the pro-
moter of TGF-𝛽 , a key cytokine involved in the differentiation of iTregs.
Whether T-bet stoichiometry is a defining parameter for the reported
competitive interaction with GATA3 to take place remains unclear,
the study identifies T-bet levels positively correlate with increased
Treg activity.
In an attempt to test preventive and therapeutic effects of admin-
istering polyI:C in a model of Th2-mediated FA, the authors gavage-
fed mice with polyI:C for a week prior to chronic feeding of OVA
and cholera toxin for 4 consecutive weeks. On the fifth week, mice
were rechallenged with high dose of OVA alone or were adminis-
tered polyI:C togetherwithOVA after establishing a similar type of FA.
Remarkably, administration with polyI:C prevented the development
of FA as well as inhibited existing FA, in a Treg-dependent manner. The
Treg dependence of polyI:C mediated beneficial effects were further
substantiated by the in vivo depletion of Tregs using anti-CD25 anti-
body, which reversed polyI:Cmediated protection after an established
FA. In conclusion, activation of TLR3 by polyI:C administration induces
IFN𝛾+ FOXP3+ Tregs, which prevented FA development and inhibited
existing FA inmice.
The biologic effects of triggering TLRs in Tregs themselves are fasci-
nating, but further research is required to reveal the versatile role and
mechanism of function of TLRs found on the surface or in endocytic
locations in Tregs. The study by Hong et al. opens a Pandora’s box
of questions, relating to which TLR isoforms are expressed at steady
states and their dynamic expression upon inflammation or infection by
local Treg subtypes. Additional questions remain unestablished with
regards to the observed effects of polyI:C augmenting T-bet expres-
sion in CD4+ T cells. What are the processes leading to increased
protein levels of T-bet? Does T-bet expression involve type I IFN
receptor signaling, particularly through IFN beta (𝛽), an antiviral
molecule as the main target of polyI:C mediated transcriptional
activity, which may then rev up the transcriptional activity on the
T-bet promoter or simply via increasing T-bet mRNA stability in an
autocrine/paracrinemanner?
The study overall opens up a new window of opportunity for
immunotherapy to treat patients with FA by shifting the balance
between immunity and tolerance. Future studies are needed for
comprehensive analyses of the molecular and biochemical processes
associated with the TLRs pathways in T cells that support their
immunosuppressive functions.
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